On Tuesday, TD Cowen analysts adjusted their outlook for shares of Charles River Laboratories International Inc. (NYSE: CRL), reducing the price target from $227.00 to $182.00 while maintaining a ...

TD Cowen analyst Thomas Fitzgerald CFA maintained a Hold rating on JetBlue Airways (JBLU – Research Report) on January 17 and set a price target of $6.00. The company’s shares closed today at ...

On Wednesday, TD Cowen reaffirmed its confidence in Netflix (NASDAQ:NFLX) stock, raising the price target to $1,150 from the previous $1,000 while maintaining a Buy rating. Currently trading at $ ...

Celsius Holdings (NASDAQ:CELH) swung lower in early trading on Wednesday after TD Cowen downgraded the energy drink stock to a Hold rating after having it set at Buy. Notably, the firm's retail ...

In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on Genmab (GMAB – Research Report). The company’s shares opened today at $21.35. Werber covers the Healthcare ...

TD Cowen assumed coverage on shares of Forte Biosciences (NASDAQ:FBRX – Free Report) in a report published on Tuesday morning, Marketbeat reports. The firm issued a buy rating on the stock.

A curated selection of the top 10 logistics and supply chain stories from 2024, reflecting key trends and themes identified by LM Group News Editor Jeff Berman—offering insights beyond popularity ...

The rise in targets in recent days, however, pushes the stock toward $360 after UBS Group raised its target on Salesforce and maintained a "neutral" rating, and Needham & Company raised the price ...

Ichor (NASDAQ:ICHR – Get Free Report) had its target price cut by equities researchers at TD Cowen from $40.00 to $38.00 in a research note issued to investors on Friday, MarketBeat reports.

On Tuesday, Forte Biosciences Inc. (NASDAQ:FBRX), a biotech company with a market capitalization of approximately $100 million, received a new Buy rating from TD Cowen, as the firm began its coverage ...